Literature DB >> 30131841

UPAR silencing reveals its role in neuroblastoma.

Natalia Kalinina1.   

Abstract

Entities:  

Keywords:  CRISPR/Cas9; neuroblastoma; trkC; uPAR

Year:  2018        PMID： 30131841      PMCID： PMC6101280          DOI： 10.18632/oncotarget.25821

Source DB:  PubMed          Journal:  Oncotarget        ISSN： 1949-2553


× No keyword cloud information.
  8 in total

1.  Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas.

Authors:  K A Rubina; V Yu Sysoeva; E I Zagorujko; Z I Tsokolaeva; M I Kurdina; Ye V Parfyonova; V A Tkachuk
Journal:  Arch Dermatol Res       Date:  2017-04-20       Impact factor: 3.017

2.  Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.

Authors:  Ekaterina Semina; Kseniya Rubina; Veronika Sysoeva; Karina Rysenkova; Polina Klimovich; Olga Plekhanova; Vsevolod Tkachuk
Journal:  Eur J Cell Biol       Date:  2016-06-03       Impact factor: 4.492

3.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

4.  Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.

Authors:  Sajani S Lakka; Christopher S Gondi; Dzung H Dinh; William C Olivero; Meena Gujrati; Velidi H Rao; Chrissa Sioka; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

5.  Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.

Authors:  Peng Li; Ya Gao; Zongzheng Ji; Xiansheng Zhang; Quan Xu; Gongcai Li; Zhengtuan Guo; Baijun Zheng; Xinkui Guo
Journal:  J Pediatr Surg       Date:  2004-10       Impact factor: 2.545

Review 6.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Niaz Mahmood; Catalin Mihalcioiu; Shafaat A Rabbani
Journal:  Front Oncol       Date:  2018-02-12       Impact factor: 6.244

7.  Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.

Authors:  Marie Ménard; Clélia Costechareyre; Gabriel Ichim; Jonathan Blachier; David Neves; Loraine Jarrosson-Wuilleme; Reinhard Depping; Jan Koster; Pierre Saintigny; Patrick Mehlen; Servane Tauszig-Delamasure
Journal:  PLoS Biol       Date:  2018-05-11       Impact factor: 8.029

8.  CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.

Authors:  Karina D Rysenkova; Ekaterina V Semina; Maxim N Karagyaur; Anna A Shmakova; Daniyar T Dyikanov; Petr A Vasiluev; Yury P Rubtsov; Kseniya A Rubina; Vsevolod A Tkachuk
Journal:  Oncotarget       Date:  2018-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.